SAN DIEGO, May 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and ...
The FDA Phexxi™ (lactic acid, citric acid and potassium bitartrate; Evofem Biosciences) vaginal gel for the prevention of pregnancy in females of reproductive potential for use as an on-demand method ...
For well over a century, people have made myriad assertions regarding the medicinal properties of cream of tartar, a cooking ingredient with the chemical name potassium bitartrate. Among the claims ...
Phexxi (lactic acid/citric acid/potassium bitartrate) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to help prevent pregnancy in people who can become ...
SAN DIEGO, Sept. 8, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that Phexxi™ (lactic acid, citric acid and potassium bitartrate), the first and only non-hormonal ...
SAN DIEGO, May 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback